The Advisory Team at Lytix Biopharma provides expert guidance on the strategic direction of the company's oncolytic peptide developments. Comprising seasoned professionals in oncology and drug development, the team evaluates clinical strategies, ensures compliance with regulatory standards, and fosters collaborations to enhance the efficacy and reach of Lytix's innovative therapies in the fight against cancer.
View all